Canopy Growth (WEED.TO) (TWMJF) has rallied 25% off its June lows and the shares have been trending higher ahead of the company’s fourth quarter and full-year earnings report.

Before the market opens on June 27th, Canopy will release its fourth quarter financial and operating results and we expect to see the company report strong numbers for the period.

Last week, Canopy Growth provided shareholders with a corporate update and the market responded very favorably to this update.

A Global Expansion Story

From Germany to Australia, this Canadian licensed medical marijuana producer continues to increase market share across the globe and we expect this trend to continue as management executes across the board.

Pacific Century Holdings Inc., a strategic partner for legalized cannabis operators and investors, today announced the opening of a $50 million real estate investment fund, PCH Fund 1, an investment vehicle capitalizing upon the scarcity of real estate assets for the cannabis industry.

The cannabis industry is poised for significant growth but continues to experience a lack of traditional capital due to disparities in federal and state law. As a result, leasing or acquiring property for marijuana operations is complex, limited and hard to obtain. PCH Fund 1 was established to capitalize on this demand by acquiring, owning and managing specialized agricultural, industrial and retail properties for lease by experienced owners of state-regulated cannabis businesses.

Alberta's latest cannabis growers said Tuesday they remain bullish about the nascent industry despite a major sell-off of pot stocks that has sent share prices tumbling for months.

After submitting its application for a production license four years ago, Airdrie's Sundial Growers secured Health Canada's approval last week, becoming the third legal producer of medical marijuana in Alberta.

The facility west of Airdrie is relatively small for the industry, at 30,000 square feet, but the company plans to break ground in the coming weeks on a $120-million grow-op spanning 400,000 square feet in the central Alberta town of Olds.

Tech investors are turning to cannabis – giving seed capital a whole new meaning.

When you hear that the th Annual Cannabis World Congress and Business Expo is in New York City and taking over a corner of the Jacob Javits Center – the 12th largest convention center in the US – attention must be paid.

California lawmakers’ approval of the state budget on last week came with a piece of attached legislation with major implications for the cannabis industry, which is in its first year as a fully regulated business sector.

SB 94 – which passed with a 31-to-3 vote – essentially merges the Medical Cannabis Regulation and Safety Act and Proposition 64, the Adult Use of Marijuana Act, into one regulatory framework that will govern both medical and recreational cannabis use. The budget rider bill, along with the rest of the budget, is currently awaiting the governor’s signature.

Recreational sales of marijuana in Nevada may not begin next month after all.

A judge added to the uncertainty Tuesday when he extended a temporary order preventing the state from issuing pot distribution licenses to existing medical marijuana dispensaries so they can begin recreational sales July 1.

Carson City District Judge James Wilson said in a 11-page ruling Tuesday that the ballot measure voters approved in November dictates that licensed alcohol wholesalers have the exclusive rights to pot distribution licenses for 18 months.

Come this fall, tourists and curious locals may be able to hop in a van, visit local cannabis farms, purchase primo bud and soak up Humboldt County’s multi-generational marijuana culture during day-long tours.

McKinleyville entrepreneur Matt Kurth is launching Humboldt Cannabis Tours, which promises “to provide the most fun, educational and authentic cannabis experience available.”

“It’s like wine tours, but cannabis,” Kurth said.

Tourists will be able to see how Humboldt County’s No. 1 cash crop is grown and will have an opportunity to sample the wares.

Producing a few pounds of weed can have the same environmental toll as driving across America seven times – harming cities’ and states’ plans to curb emissions.

As he opens the steel door to the jumble of his office, located in a cloistered warehouse on the west side of Denver, Paul Isenbergh is barking down the phone about a duplicitous business rival. He’s wearing a shirt and rust-colored tie. Yards from his desk, rows of drying cannabis plants are strung up on two clothes lines.

Isenbergh spent 30 years as a real estate broker in Florida. When he moved to Denver in 2011, he didn’t even know medicinal marijuana was legal in Colorado. 

INTIVA BioPharma Inc. has filed a provisional patent application with the United States Patent Office for methods and compositions for treating lipidosis. The methods comprise the administration of a drug comprising of one or more cannabinoids and/or terpenes.

Lipidosis is a term used to describe various lysosmal storage diseases in which there is an abnormal accumulation of lipids in the reticuloendothelial cells. Examples of lipidosis conditions include Gaucher’s Disease, Neimann-Pick Disease, Fabry’s Disease, Wolman’s Disease, van Bogaert’s Disease, Generalized (GM1) ganliosidosis, Tay-Sachs Disease, Sultatide Lipidosis and Krabbe’s Disease.

If illicit pot plants flourishing covertly in the Colombian countryside represent the marijuana industry’s past, then Canada’s commercial-scale medical licensing system represents its future.

PharmaCielo Ltd., a privately held medical marijuana producer with global ambitions, is hoping to capitalize on both those traditions.

The company, which has board members from U.S. big tobacco and big pharma, is headquartered in Canada — a decision made due to this country’s sophisticated medical cannabis regulations, friendly financial markets and growing base of accountants, lawyers and bankers with cannabis expertise.